1. Home
  2. XBP vs LSTA Comparison

XBP vs LSTA Comparison

Compare XBP & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBP Europe Holdings Inc.

XBP

XBP Europe Holdings Inc.

HOLD

Current Price

$2.85

Market Cap

24.4M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.24

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBP
LSTA
Founded
N/A
1980
Country
United States
United States
Employees
10200
N/A
Industry
Business Services
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
28.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
XBP
LSTA
Price
$2.85
$2.24
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$15.00
AVG Volume (30 Days)
10.8K
26.3K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
$2.59
N/A
Revenue Next Year
$5.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.41
$1.81
52 Week High
$8.55
$5.07

Technical Indicators

Market Signals
Indicator
XBP
LSTA
Relative Strength Index (RSI) 60.37 23.92
Support Level $2.11 $1.87
Resistance Level $3.00 $2.61
Average True Range (ATR) 0.25 0.20
MACD 0.04 -0.06
Stochastic Oscillator 57.69 13.71

Price Performance

Historical Comparison
XBP
LSTA

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: